GlassScriptPhysician profile
Joseph D Ogorman
NPI 1730178179
$2,227.50
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $159 · 2021: $819 · 2022: $660 · 2023: $221 · 2024: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $342.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $657.45 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $340.28 | 2021-2022 | |
| Vifor Pharma, INC. | $188.02 | 2019-2022 | |
| Fresenius USA Marketing, INC. | $173.88 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $134.13 | 2021 | |
| Csl Behring | $121.51 | 2024 | Kcentra |
| Abbvie INC. | $110.90 | 2023 | |
| Daiichi Sankyo INC. | $110.32 | 2021 | |
| Corcept Therapeutics | $109.65 | 2023 | Korlym |
| Opko Pharmaceuticals, LLC | $69.69 | 2019-2022 | |
| Medtronic, INC. | $50.30 | 2021 | |
| Amgen INC. | $23.46 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $23.36 | 2022 | |
| Calliditas Therapeutics US INC. | $22.83 | 2022 | |
| Abbott Laboratories | $19.55 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $17.17 | 2021 | |
| Mallinckrodt Hospital Products INC. | $16.52 | 2020 | |
| Akebia Therapeutics INC | $13.37 | 2021 | |
| Janssen Pharmaceuticals, INC | $12.56 | 2020 | |
| Renalytix Ai, INC. | $12.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Ogorman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.